Re:Toxoplasma Gondii significantly alters wolf behavior
by chasil on Wednesday May 29, 2024 @11:38PM
(#40519841)
The question is how your medication interacts with "somatic hypermutation" which enables your dendritic cells to launch the cascade via t-cells which triggers antibody production by your b-cells.
It would be useful to understand how your medication interacts with this process.
Somatic hypermutation has a small discussion in the Kerzegast book.
I understand that somatic hypermutation, by the removal of uracil, plays two roles, first in initial recognition of a pathogen, then second in tuning the response for variants.
As I understand it, this only happens in germinal centers, the lymph nodes.
It would be useful to understand how your medication interacts with this process.
https://m.youtube.com/watch?v=lXfEK8G8CUI
Somatic hypermutation has a small discussion in the Kerzegast book.
I understand that somatic hypermutation, by the removal of uracil, plays two roles, first in initial recognition of a pathogen, then second in tuning the response for variants.
As I understand it, this only happens in germinal centers, the lymph nodes.
https://www.scribd.com/document/664375598/IMMUNE-by-Philipp-...
This is a question for an infectious disease specialist.